Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axisLin Xie, Yun Zhang, Wenhai Sui et al.|Signal Transduction and Targeted Therapy|2024Cited by 34
CD19 Chimeric Antigen Receptor T-cell Shows Activity in Patients with B-cell Lymphoma Without CD19 Expression by ImmunohistochemistryTao Wang, Jian-Min Yang|Research Square|2021Cited by 0